Dermira
develops and commercializes therapeutics for the treatment of dermatological diseases... Read moreDermira
develops and commercializes therapeutics for the treatment of dermatological diseases... Read more
News
Apr 01, 2021
BioSpace
Dermira: Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc., a Wholly-Owned Subsidiary of Eli Lilly and Company, to Acquire QBREXZA
Apr 01, 2021
centralcharts
Press Release: Dermira : Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc., a Wholly-Owned Subsidiary of Eli Lilly and Company, to Acquire QBREXZA
Jan 07, 2021
Endpoints News
Dermira: Dermira vets license back candidates from Eli Lilly to launch their own upstart
Jan 07, 2021
BioSpace
Dermira: Evommune In-Licenses Three Development Programs Focused on Treating Inflammatory Conditions from Dermira, a Wholly-Owned Subsidiary of Eli Lilly and Company
Oct 23, 2020
The Business Journals: San Francisco Business Times
Dermira: Months after $1 billion buyout, Peninsula company, Lilly face generic challenge
Jun 13, 2020
BioSpace
Dermira: Lilly and Dermira Present New Lebrikizumab Phase 2b Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life
Mar 19, 2020
TheMarketsDaily
Dermira: Reviewing Dermira (NASDAQ:DERM) and Neurotrope (NASDAQ:NTRP
Mar 02, 2020
MarketScreener
Dermira: Dermira : Form 15-12B - Securities Registration Termination
Feb 21, 2020
FinSMEs
Dermira: Eli Lilly and Company Closes Acquisition of Dermira
Feb 20, 2020
MarketScreener
Dermira: Dermira : SEC Filing - POS AM
